| |
The 2008 Frost & Sullivan Global Polymerase Chain Reaction Product of the Year Award has been awarded to Spartan Bioscience Inc., a Canadian molecular diagnostics company. The company is recognised for its pioneering Spartan DXTM DNA analyser. This innovative, portable DNA analyser designed for the molecular biology market is aimed at small scale, on-demand DNA analysis. With a unique value proposition in the research and clinical markets, Spartan's innovative product offering is poised to experience widespread market acceptance.
"The Spartan DX DNA analyser finds an exclusive place in the molecular biology market as the need for small scale DNA analysis is yet to be fulfilled," notes Frost & Sullivan Research Analyst Arun A.K. "With strong qualitative results, this portable DNA analyser represents a major breakthrough in polymerase chain reaction (PCR) technology."
Launched in June 2007, the Spartan DXTM DNA analyser is a portable and compact analyser that has been designed for non-batched, on-demand DNA applications with a major focus on convenience and affordability. A perfect match for low throughput analysis, this analyser is a boon for researchers and clinicians as it addresses the need for small scale analysis as a complement to the batched PCR workflows that dominate the industry.
This product gives Spartan the competitive edge as it enjoys first mover advantage in the small volume analyser market. The Spartan DX DNA analyser has already received positive feedback from its customers within a short period of its launch.
Clients have lauded the analyser as being an ideal fit for bacterial microbiology laboratories in developing nations as it is relatively inexpensive. Moreover, it has been commended for being compact, easy-to-use, giving results faster than most PCR instruments, and being well-suited for analysing single samples. As such, the Spartan DX is extremely effective for occasional STAT testing: the analysis of occasional but important 'rush' specimens that fall outside the routine testing schedule of the diagnostic virology laboratory.
"After having been successfully introduced in research labs in Canada and the USA, Spartan Bioscience is now actively exploring broader global markets to expand its presence," states Arun. "With an expanding distribution network, Spartan Bioscience is preparing to revolutionise the PCR market with its first-to-market, on-demand DNA analyser."
The Frost & Sullivan Award for Product of the Year is presented each year to the company that has demonstrated excellence in new product development and launch within its industry. The recipient company has shown innovation by its plans to launch a broad line of emerging products and technologies.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Spartan Bioscience
Spartan Bioscience Inc. (spartanbio.com) is a privately-held molecular diagnostics company that develops, manufactures, and markets Polymerase Chain Reaction (PCR) DNA analysers for on-demand applications. The company is focusing on applications where rapid and convenient DNA testing is particularly important, such as low-throughput research experiments and non-batched testing for infectious diseases.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.
|
jasmine.malone[.]frost.com 
